Updated time: 2023-12-12 14:27:31
03A-1060922
US 11,266,603 B2、 TW I770396、US 11,771,651B2
In our invention, instead of using potentially toxic unnatural lipids, we use intelligent peptide to control liposomal drug release. These peptides allow liposomal drugs to be selectively released upon intended (disease) signals. Triggered-release peptidyl liposome (other than pH as signal) was never successful due to the suitable membrane lytic peptide sequence had not been found. The discovery and designs in this invention make signal-sensing peptide-anchored functional liposome feasible.
Most of trigger-release liposome designs require a high equivalence/stoichiometry of unnatural synthetic lipids as a switch to facilitate release, but the toxicity and biocompatibility of the unnatural lipid remains a concern. Although peptide is a much safer chemical entity, there are only very few successful trigger-release peptidyl liposome designs are reported, and most of them use endosomal pH, which is not practical trigger in clinical use. In this invention, the suitable sequence of intelligent peptide that can provide excellent membrane lytic activity upon varieties of triggers has been discovered. This intelligent membrane lytic peptide can also be custom-tailored to response to other intended trigger signal into membrane lytic signal for release.
Intelligent, trigger-responsive liposomes using membrane anchored-peptide has been developed in our lab. These intelligent membrane lytic peptide can be used to generate smart peptidyl liposomes to provide release of toxic chemotherapeutics upon intended signals, such as tumor-associated enzymes (metalloproteinase and phosphatase). Compare with the conventional liposome, trigger-release liposome greatly lowers the systemic toxicity by providing fast release only at intended site where has intended signals. Not only chemotherapeutics can be encapsulated for tumor treatment, MRI contrast agent can also be encapsulated into this trigger-release vesicle to generate a powerful diagnostic imaging tool to visualize the location of specific enzymes secreted by malignant tissues.
Hsien-Ming Lee
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Control-Release Smart Liposome Preparation by Trigger- Responsive Membrane Lytic Peptide